Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...

Tempus AI stock surged to a record-high Monday after the Food and Drug Administration cleared its new device to help ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

RNA sequence design and inverse folding constitute pivotal areas in computational biology, aiming to identify nucleotide sequences that adopt predetermined structural conformations. The inverse ...

Background Molecular genetic diagnoses are critical to prevention and treatment of inherited polyposis and colorectal cancer.

The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in ...

Plant scientists discovered hidden stem cell regulators tied to growth and crop size. Their breakthrough could transform how we grow food, fuel, and resilient harvests.